Kelly Wulf, PA
Medical · Portland, ORNPI 1750654323
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations.
Across 81 payments — averaging $29.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$417
- AbbVie$275
- Novartis$255
- E.r. Squibb & Sons, L.L.C.$230
- Regeneron Healthcare Solutions, Inc.$219
- Sanofi$212
- plus $784 from 9 others
What the payments were for
- Food & beverage$2,19192%
- Education$2018%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 22 | $417 |
| AbbVie | 15 | $275 |
| Novartis | 14 | $255 |
| E.r. Squibb & Sons, L.L.C. | 3 | $230 |
| Regeneron Healthcare Solutions, Inc. | 5 | $219 |
| Sanofi | 3 | $212 |
| Johnson & Johnson | 5 | $206 |
| UCB, Inc. | 3 | $161 |
| Incyte Corporation | 1 | $125 |
| Pfizer | 4 | $119 |
| Arcutis Biotherapeutics, Inc. | 1 | $86 |
| Galderma Laboratories, L.p. | 2 | $46 |
| Amgen | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
| Organon | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,391 in reported general payments places this provider in the 85th percentile of 364 medical providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Unoready PenSecukinumab | 12 | $129,033 |
| Dupixent PenDupilumab | 21 | $86,499 |
| Betamethasone Dipropionate | 87 | $3,208 |
| Metronidazole | 74 | $3,074 |
| Clobetasol Propionate | 66 | $2,627 |
| Doxycycline Monohydrate | 42 | $1,172 |
| Triamcinolone Acetonide | 98 | $1,121 |
| Fluorouracil | 15 | $1,051 |
| Ketoconazole | 53 | $711 |
| CiclopiroxCiclopirox Olamine | 15 | $484 |
| Doxycycline Hyclate | 17 | $410 |
| Mupirocin | 31 | $341 |
| Cefdinir | 18 | $310 |
| Hydrocortisone | 41 | $295 |
| Minoxidil | 24 | $238 |
Paid to pharmacies, not to this prescriber.
Other medical in Portland
- Britt BennPortland$11K
- Erica BallardPortland$8K
- Kimberly SandersPortland$5K
- Cody BallardPortland$4K
- Margaret NgPortland$4K
- Dmitriy ShorePortland$3K
- Bridget LahmPortland$3K
- Mary TeggerPortland$3K
- Maureen BaileyPortland$3K
- Tara PembertonPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.